The possibility of type 2 diabetes (T2D) remission has been widely debated in recent years, primarily due to studies investigating the effects of calorie restriction and weight loss on glycemic control. However, experts warn that achieving normal blood glucose and glycated hemoglobin levels does not necessarily mean disease reversal. “At the time of diagnosis, approximately … Read more
The National Institute for Health and Care Excellence (NICE) has proposed annual body mass index (BMI) checks for patients in England with long-term conditions. In draft guidance, the regulator also suggested measuring waist-to-height ratios for those with a BMI below 35. Identifying Risks and Improving Care NICE said the new approach would help identify people … Read more
This transcript has been edited for clarity. Monica Peek: Hi. I’m Dr Monica Peek, and this is Care Cues. I’m thrilled to be joined with my colleague and friend, Sheila Harmon. Thanks for joining us. Today, we’re going to be talking about shared decision-making for patients who have type 2 diabetes and are African American. … Read more
Tirzepatide Shows Promise in Reducing cardiovascular Risk for Obese heart Failure Patients A new analysis of the SUMMIT trial reveals that the glucagon-like peptide 1 (GLP-1) agonist tirzepatide significantly lowers the risk of cardiovascular (CV) events in patients with obesity and heart failure with preserved ejection fraction (HFpEF). This benefit remains consistent nonetheless of whether … Read more
The glucagon-like peptide 1 (GLP-1) agonist tirzepatide lowers the risk for cardiovascular (CV) events in patients with obesity and heart failure with preserved ejection fraction (HFpEF), whether they have general adiposity, measured with the body mass index (BMI), or central adiposity, measured with the waist-to-height ratio, showed a new analysis from the SUMMIT trial. This … Read more
GLP-1s for HFpEF: Better Outcomes With Patient-Centered Care Medscape Source link
Study population Using NHANES data, this cross-sectional study aims to determine the significance of NHHR in relation to MASLD. NHANES is an extensive survey conducted nationally to observe the health and nutritional conditions of individuals throughout the United States. What sets it apart is its integration of interviews, physical assessments, and laboratory analyses. The data … Read more
Practiced for centuries as a ritual in many religions, intermittent fasting (IF) is rapidly growing in popularity as a weight loss and health-improvement tool. A 2024 survey found that as many as 13% of Americans followed an IF regimen during the previous year. But does it really offer health benefits? And are there any downsides? … Read more
Treatment with the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide had no disease-modifying effects on movement, symptom severity or brain imaging in patients with Parkinson’s disease (PD) enrolled in a phase 3 trial. “The results of this trial have been eagerly anticipated, and the negative results will be a major disappointment to patients affected by … Read more
This transcript has been edited for clarity. Welcome to the second video on the American Diabetes Association’s Standards of Care in Diabetes—2025. We’re starting with Section 5, “ Facilitating Positive Health Behaviors and Well-Being to Improve Health Outcomes.” The section emphasizes the notion that people really need to be referred for diabetes self-management education and … Read more